Oral and Maxillofacial Surgery

Development of a proficiency based microsurgical training course and the demonstration of progression of junior OMFS trainees

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Development of a proficiency based microsurgical training course and the demonstration of progression of junior OMFS trainees

Introduction: It is recognized that simulation can be used to aid the training of surgeons. Many courses give participants a certificate of completion rather than one of competence or proficiency….

read more

Low Annexin A1 expression is predictive for a benefit from induction chemotherapy in oral cancer patients with moderately/poorly pathologic differentiation grade

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Low Annexin A1 expression is predictive for a benefit from induction chemotherapy in oral cancer patients with moderately/poorly pathologic differentiation grade

Background: The benefits of induction chemotherapy in oral squamous cell carcinoma (OSCC) remain to be clearly defined, as trials to date have not shown a major survival benefit when induction…

read more

Propranolol inhibited angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Propranolol inhibited angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell

Oral propranolol (PRN) has recently been shown to be highly effective for infantile hemangiomas (IHs), and is currently recommended as the first-line treatment of complicated IHs. However, no pharmacokinetic parameters…

read more

Novel role for the transient receptor potential channel TRPM2 in proliferation and apoptosis of human tongue carcinoma cell

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Novel role for the transient receptor potential channel TRPM2 in proliferation and apoptosis of human tongue carcinoma cell

Objective: To investigate the expression of Transient Receptor Potential Melastatin type 2 (TRPM2) in the human tongue squamous cell carcinoma tissues and SCC cell lines. The effect of activated and…

read more

Association between gene polymorphisms with oral squamous cell carcinoma risk and survival in multiple ethnicities: a systematic review

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Association between gene polymorphisms with oral squamous cell carcinoma risk and survival in multiple ethnicities: a systematic review

Background: There are more than 30 genes polymorphisms associated with risk and survival rate of oral squamous cell carcinoma (OSCC). Nevertheless, different ethnicity could show different genotype and allele as…

read more

Gemcitabine induces phenotypic alterations of tumor cells that facilitate antitumor T cell responses in a mouse model of oral cancer

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Gemcitabine induces phenotypic alterations of tumor cells that facilitate antitumor T cell responses in a mouse model of oral cancer

Background and objectives: Gemcitabine (GEM) is a pyrimidine nucleoside analogue that is a new chemotherapeutic agent used for treating various cancers. Because accumulating evidence indicates that GEM may activate host…

read more

Discrepancy between clinical and pathological staging of head and neck cancer – ‘the stage migration’

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Discrepancy between clinical and pathological staging of head and neck cancer – ‘the stage migration’

Rationale: The TNM system for classification of Head and neck malignant tumours is a universally accepted, widely used, staging method which helps clinicians and researchers to choose from treatment options,…

read more

Continued monitoring of salivary interleukin-6 levels may predict early and late locoregional recurrence in patients with oral squamous cell carcinoma

Jan 21, 2018 by in Oral and Maxillofacial Surgery Comments Off on Continued monitoring of salivary interleukin-6 levels may predict early and late locoregional recurrence in patients with oral squamous cell carcinoma

Background and objective: We have already demonstrated that post-operative concentration of salivary interleukin-6 (IL-6) may predict early locoregional recurrence in oral squamous cell carcinoma (OSCC) (Head & Neck; 2012). This…

read more
Get VIDEdental app for watching clinical videos